Abstract
Epithelial to mesenchymal transition (EMT) plays an important role in embryonic development, tissue regeneration, and cancer metastasis. Whereas several feedback loops have been shown to regulate EMT, it remains elusive how they coordinately modulate EMT response to TGF-β treatment. We construct a mathematical model for the core regulatory network controlling TGF-β-induced EMT. Through deterministic analyses and stochastic simulations, we show that EMT is a sequential two-step program in which an epithelial cell first is converted to partial EMT then to the mesenchymal state, depending on the strength and duration of TGF-β stimulation. Mechanistically the system is governed by coupled reversible and irreversible bistable switches. The SNAIL1/miR-34 double-negative feedback loop is responsible for the reversible switch and regulates the initiation of EMT, whereas the ZEB/miR-200 feedback loop is accountable for the irreversible switch and controls the establishment of the mesenchymal state. Furthermore, an autocrine TGF-β/miR-200 feedback loop makes the second switch irreversible, modulating the maintenance of EMT. Such coupled bistable switches are robust to parameter variation and molecular noise. We provide a mechanistic explanation on multiple experimental observations. The model makes several explicit predictions on hysteretic dynamic behaviors, system response to pulsed stimulation, and various perturbations, which can be straightforwardly tested.
Introduction
Epithelial to mesenchymal transition (EMT) is defined as the conversion of epithelial cell to mesenchymal cell, characterized by loss of cell-cell adhesion and increased cell motility (1,2). EMT plays important roles in embryonic development and tissue regeneration (2,3). In addition, inappropriate utilization of EMT may lead to pathological processes, such as fibrosis and cancer metastasis (3). Thus, in both physiological and pathological contexts, understanding the regulation of EMT process is fundamental for prevention and treatment of cancer metastasis and organ-degenerative diseases.
EMT can be induced by a plethora of stimuli, of which transforming growth factor-β (TGF-β) is a major and very potent inducer (4). Several crucial transcription factors are involved in a TGF-β mediated EMT, including SNAIL1/2 and ZEB1/2. They directly repress the expression of the epithelial state (E state) marker E-cadherin, while promoting the induction of the mesenchymal state (M state) marker N-cadherin (3). Several miRNAs also are involved in regulating EMT, of which miR-34 and miR-200 are the most studied (5). Moreover, the transcription factors and miRNAs are linked by several feedback loops. One is the double-negative feedback loop between ZEB1/2 (collectively referred to as “ZEB” thereafter) and the miR-200 family (miR-200a, miR-200b, miR-200c, miR-141, and miR-429), in which ZEB1/2 represses the expression of miR-200 whereas miR-200 negatively regulates the translation of ZEB1/2 (6–8). The other double-negative feedback loop occurs between SNAIL and miR-34a/b/c (collectively referred to as “miR-34” thereafter) in a similar way (9,10). Furthermore, release of miR-200-mediated inhibition of TGF-β is required to maintain a stable mesenchymal phenotype (11). That is, several coupled positive feedback loops seemingly function redundantly to regulate the process. It remains to be fully understood how these feedback loops coordinately modulate EMT response to TGF-β treatment.
EMT is classically viewed as a switch that converts the static, ordered epithelia into labile, individual mesenchymal cells. However, EMT is not always an all-or-none response. In addition to the epithelial and mesenchymal states, reports exist on an intermediate phenotype in the process of EMT, known as the partial EMT (pEMT) state (12–16). The partial EMT state retains some characteristics of epithelium but also shows features of mesenchymal cells (17). Notably, pEMT is a metastable, reversible phenotype (18), whereas complete EMT is not. The existence of the epithelial, pEMT, and mesenchymal states leads us to hypothesize that complete EMT may be a sequential multistep program. Then the question is how these three states are generated from the regulatory network, and how partial EMT is reversible whereas full EMT is irreversible.
Several mathematical models have been developed to explore the dynamics of TGF-β signaling pathway in epithelial mesenchymal transition (19–22). In contrast to these two-compartment models, Vilar et al. built a trafficking-coordinate model to accurately capture the distinct TGF-β signaling dynamics (23). However, these models only focus on the quantitative dynamic of Smad nucleo-cytoplasmic shuttling and do not take into account the downstream of Smad signal, such as SNAIL1/miR-34 and ZEB/miR-200 double-negative feedback loops. Thus, it remains to be further elucidated how the cell fate is coordinately determined during TGF-β-induced EMT.
Motivated by the above consideration, in this work we perform a systematic mathematical analysis on the core regulatory network for EMT, addressing the relation between the network structure and its functional roles. In the remaining sections, we will first present the network constructed by integrating existing experimental studies, then discuss its deterministic and stochastic dynamic behaviors in response to exogenous TGF-β treatment and associate the network dynamics with cellular outcomes. We conclude with discussions on how the design of the network matches its functional requirements, and propose future experimental studies for testing the predictions from our simulation.
Model and Methods
Fig. 1 gives a schematic diagram of the core regulatory network. Autocrine or exogenous TGF-β promotes the expression of snail1 mRNA (24), which is translated to SNAIL1 protein. SNAIL1 promotes the transcription of zeb, which is translated to ZEB. Experimental studies reveal two core double-negative feedback loops between transcription factors and miRNAs. The first one is between SNAIL1 and miR-34 (9,10). SNAIL1 inhibits transcription of miR-34, which represses translation of snail1, enclosing a double-negative feedback loop. The other one is between ZEB and miR-200 (6–8). ZEB represses transcription of miR-200, which inhibits translation of zeb, enclosing the other double-negative feedback loop. miR-200 also inhibits the autocrine expression of TGF-β (11), making another feedback loop. As the marker of epithelial cells, E-cadherin is inhibited by SNAIL1 and ZEB, whereas the marker of mesenchymal cells N-cadherin is promoted by SNAIL1 and ZEB (3). Table S1 in the Supporting Material summarizes the experimental support of the regulatory network. We first describe the dynamics of proteins, mRNAs, and miRNAs with a set of ordinary differential equations, then study the effect of noises with stochastic simulations. We use the following set of ordinary differential equations to model the deterministic dynamics of the core regulatory network:
| (1) |
| (2) |
| (3) |
| (4) |
| (5) |
| (6) |
| (7) |
| (8) |
| (9) |
where [T], [s], [S], [R3], [z], [Z], [R2], [E], and [N] denote the concentrations of endogenous TGF-β, snail, SNAIL, miR-34, zeb, ZEB, miR-200, E-cadherin, and N-cadherin, respectively. Regulation of the transcription of each gene is characterized by the Hill function, which is often used to represent the regulation of the transcription of an unknown gene (25,26). Currently there is no experimental data on the response curve of the gene expression level versus the transcription factor level. For simplicity, we choose all the Hill coefficients to be 2 to allow sufficient nonlinearity. Table S2 and Table S3 list the definition and initial value of each variable and a set of standard parameter values, respectively. The default state is the epithelial phenotype, in which the concentration of each species is set to its stable steady-state value in the absence of exogenous TGF-β treatment (i.e., TGF0 = 0).
Figure 1.

Schematic depiction of the core regulatory network. Exogenous or endogenously expressed TGF-β promotes the expression of snail1 mRNA, which is translated to SNAIL1. SNAIL1 promotes the transcription of zeb mRNA, which is translated to ZEB. SNAIL1 inhibits the expression of miR-34, which represses the translation of snail1, forming a double-negative feedback loop. ZEB represses the induction of miR-200, which inhibits the translation of zeb, forming another double-negative feedback loop. The autocrine expression of TGF-β is also inhibited by miR-200. As the marker of epithelial cell, E-cadherin is inhibited by SNAIL1 and ZEB, whereas the marker of mesenchymal cell, N-cadherin, is promoted by SNAIL1 and ZEB.
Intrinsic noise that results from low copy numbers of mRNAs and miRNAs per cell can affect all the biological processes (27). However, there are some systems that can function deterministically even when the average number of number of mRNA molecules is <1 (28). To investigate the stochastic effects of the finite number of molecules on the dynamics of EMT system, we also build a stochastic version of the model, which generally can be described by birth-and-death stochastic processes governed by chemical master equations. By introducing a system size factor Ω, we change the concentration of each molecular to its number, i.e., xi = [xi] ⋅ Ω. Table S4 lists all the reactions involved. We use the τ-leap-based stochastic Gillespie algorithm to simulate the stochastic model (29,30). To account for cell-to-cell variability in population level, we also add extrinsic noise in the model as static parameter value variations. In these single-cell based simulations, every parameter value of a cell is randomly and uniformly chosen from 85 to 115% of its default value with Latin Hypercubic sampling.
Results
Epithelial to mesenchymal transition is a sequential two-step program
Fig. 2 shows the deterministic dynamics of proteins and miRNAs under different levels of constant exogenous TGF-β treatment. There are two possible cell fates in response to TGF-β treatment. When the level of the exogenous TGF-β is limited, e.g., 1.8 units (ng/mL) (Fig. 2 A), the mRNA of snail1 is induced quickly. However, SNAIL1 protein level does not go up until the repression of translation mediated by miR-34 is removed later. Notably, the levels of ZEB and miR-200 barely change throughout the time. Furthermore, endogenous expression of TGF-β is not activated. E-cadherin is partially inhibited and N-cadherin is partially activated. That is, the cell shows both epithelial and mesenchymal traits, consistent with the experimentally observed feature of partial EMT (17).
Figure 2.

Epithelial to mesenchymal transition is a sequential two-step program. (A) The dynamics of partial EMT at 1.8 units treated with exogenous TGF-β. (B) The predicted (solid lines) and experimentally measured (circles) dynamics of full EMT at 3.0 units treated with exogenous TGF-β. The experimental data on the MDCK cell line is quantified from Bracken et al. (7).
When the level of the exogenous TGF-β increases, e.g., 3.0 units, the cell converts to a different cell type (see Fig. 2 B). The network dynamics then undergoes a biphasic response. In the early stage, SNAIL1 is expressed and miR-34 is silenced. This induces partial inhibition of E-cadherin expression and partial activation of N-cadherin expression, and thus the cell reaches the pEMT state. In this case, the exogenous TGF-β induces full expression of SNAIL1, which then induces transcription of zeb. Again, the increase of ZEB protein level is well delayed because of the translational repression mediated by miR-200. Eventual expression of both SNAIL1 and ZEB induces full inhibition of E-cadherin expression and full activation of N-cadherin expression, and finally shifts the cell to the mesenchymal state. Furthermore, the autocrine expression of TGF-β is activated in the second phase after miR-200-mediated inhibition is released. The predicted biphasic dynamics is in good agreement with the experimental data, which is quantified from Bracken et al. (7). A clearer biphasic dynamics can be seen from the results with another human cell line MCF10A, shown in Fig. S1 in the Supporting Material where more time-course data points are available. Taken together, EMT is a sequential two-step programming, first to partial EMT and then to full EMT.
The two-step dynamics of EMT results from sequential activation of two bistable switches
Close examination of the network in Fig. 1 suggests that the dynamics of EMT is governed by a cascade action of two bistable switches: one shifts the cell to pEMT state and the other triggers the cell to full EMT. This mechanism can be clearly seen from the one-parameter bifurcation analysis in Fig. 3 A, which shows dependence of the steady states of N-cadherin on the exogenous TGF-β level. There are three distinct branches (solid lines) in the bifurcation diagram, indicating existence of three types of stable steady states: E (blue lower branch), pEMT (green middle branch), and M (red upper branch). These three states are governed by two bistable switches. Suppose that one cell originally starts in the lower branch corresponding to the E state. Upon gradually adding exogenous TGF-β, the N-cadherin level jumps to the middle branch after it crosses the first saddle-node bifurcation point SN1. That is, the cell is transited to the pEMT state from the E state. While at the pEMT state, if the exogenous TGF-β level decreases beyond another saddle-node bifurcation point (SN2), the N-cadherin level shifts back to low level corresponding to the E state. The exogenous TGF-β level at SN1 is larger than that at SN2 and the latter is larger than zero. That is, the transition from E to pEMT state is governed by one reversible bistable switch.
Figure 3.

The biphasic EMT dynamics results from two coupled bistable switches. (A) Bifurcation analysis of N-cadherin level versus the exogenous TGF-β level. (B–D) Phase diagrams showing N-cadherin maximum and end-point values for cells subjected to pulse treatment of exogenous TGF-β with different values of strength and duration.
When the level of exogenous TGF-β is larger than that at SN3, the N-cadherin level is shifted to the upper branch from the middle branch, i.e., the cell is transited to the M state from the pEMT state. At the M state, the cell stays on this state even if the exogenous TGF-β is removed. Actually, there is another saddle-node bifurcation point SN4 on the negative side of the axis, which cannot be reached by the system physically. That is, the transition from the pEMT to the M state is governed by one irreversible bistable switch.
Fig. 3, B–D, gives a full spectrum of the system dynamics under pulsed exogenous TGF-β with values of different strength and duration. The maximum level of N-cadherin shows three regions in the plane of strength and duration of exogenous TGF-β. Treatment of exogenous TGF-β in the light-shaded (yellow online) region triggers the cell to pEMT. However, the cell recovers back to E state after the stimulus is withdrawn because the endpoint level of N-cadherin recovers to low level, showing the reversibility of partial EMT. In contrast, the treatment of exogenous TGF-β in the dark-shaded (red online) region triggers the cell to full EMT and maintains it in the M state after the stimulus is withdrawn, exhibiting the irreversibility of the full EMT. Therefore, complete EMT requires both a minimal duration and a minimal strength of TGF-β treatment.
To see whether this conclusion depends heavily on parameter values, we perform parameter sensitivity analysis to systematically explore how the features of two switches change upon varying each of the 33 parameters in the feedback loops and the Hill coefficients. The variation of the parameters in the expression of E-cadherin and N-cadherin do not change four thresholds. The thresholds for activation of partial EMT and full EMT are the corresponding exogenous TGF-β levels at SN1 and SN3, respectively. The reversibility/irreversibility of partial/full EMT is determined by the sign of the corresponding exogenous TGF-β level at SN2/SN4. First from Fig. 4 A, all the four saddle-node points are distributed around that under the standard parameter set when each parameter is increased or decreased by 15% with respect to the standard parameter set. Notably, one sees that the corresponding exogenous TGF-β level at SN2 is always positive whereas that at SN4 is always negative under this parameter variation. That is, the first switch is robustly reversible whereas the second one is robustly irreversible with this degree of parameter variation.
Figure 4.

Parameter sensitivity of the two bistable switches. (A) The level of exogenous treatment of TGF-β at the four saddle-node bifurcation points SN1∼4 when each of 33 parameters in the coupled feedback loops and the Hill coefficients is increased or decreased by 15% with respect to the standard parameter set. (B) Percentage of changes in the levels of exogenous TGF-β at SN1∼4 compared to that with the standard parameter set.
We then further calculate the percentage of changes in four thresholds in Fig. 4 B. The thresholds for the first switch are sensitive to the parameters in the SNAIL1/miR-34 feedback loop, whereas the thresholds for the second switch are sensitive to the parameters in both the SNAIL1/miR-34 and ZEB/miR-200 feedback loops. Furthermore, SN4 is also sensitive to the parameters associated with the autocrine expression of TGF-β, implying the regulation of autocrine TGF-β on the irreversibility of the second switch. We will come back to this point later. In summary, the EMT network has a robust basic feature of a reversible bistable switch coupled to an irreversible bistable switch.
Coupled positive feedback loops are responsible for the two bistable switches
The above analysis demonstrates that the dynamics of EMT is governed by two bistable switches. To reveal the underlying mechanism for these two bistable switches, we examine the dependence of steady-state levels of SNAIL1, miR-34, ZEB, miR-200, and the endogenous TGF-β on the exogenous TGF-β level, as shown in Fig. 5 A. When the exogenous TGF-β level is less than that at SN1, the expression level of SNAIL1 is low, and that of miR-34 is high. They switch their dominance at SN1. The expression level of SNAIL1 changes dramatically again at SN3. The miR-34 levels for the pEMT and M states are both very low and hardly distinguishable. However, experimentally, if one starts to reduce the exogenous TGF-β level, the system initially at pEMT state can eventually jump back to the high miR-34 level E state. On the other hand, the system initially at M state will maintain a low miR-34 level.
Figure 5.

Bifurcation analysis indicates that EMT is initiated by the Snail1/miR-34 regulatory loop, and stabilized by the ZEB/miR-200 regulatory loop. (A) Bifurcation diagrams of SNAIL1, miR-34, ZEB, miR-200, and endogenous TGF-β on the level of exogenous TGF-β. (B) Dependencies of the thresholds for activation of partial EMT and full EMT on the strength of the SNAIL1/miR-34 feedback loop (JSNAIL and J34) and the strength of the ZEB/miR-200 feedback loop (JZEB and J200).
In contrast, only the two bifurcation points at SN3 and SN4 (in the negative side of axis) are easily detectable in the signal response curves of ZEB, miR-200, and autocrine TGF-β. When the exogenous TGF-β level is larger than that at SN3, ZEB is expressed whereas miR-200 is inhibited. That is, ZEB and miR-200 dominate alternatively with the second switch on and off, respectively. Thus, the second irreversible bistable switch depends on the ZEB/miR-200 feedback loop. Turning on the second switch also activates the autocrine expression of TGF-β, which amplifies the level of SNAIL1 to further level, and leads to the four clear bifurcation points on the response curve of SNAIL1.
It is well known that positive feedback loop is a basic motif to function as a bistable switch (31–34). To further investigate the correlation between two bistable switches and SNAIL1/miR-34 and ZEB/miR-200 double-negative feedback loops, Fig. 5 B shows the dependence of the two thresholds for activation of partial EMT and full EMT on the feedback strength of two loops. For simplicity, the Michaelis constant of mutual inhibition between SNAIL1 and miR-34 (JSNAIL, J34) are chosen to characterize the feedback strength of the first loop, whereas the Michaelis constant of mutual inhibition between ZEB and miR-200 (JZEB, J200) are chosen to characterize the feedback strength of the second loop. Both thresholds decrease with the increase of JSNAIL while increasing with J34. That is, both induction of partial EMT and full EMT can be regulated by SNAIL1/miR-34 feedback loop. By contrast, only the threshold for full EMT induction is regulated by the feedback strength of the second loop. Thus, EMT is initiated by Snail/miR-34 regulatory loop, and stabilized by ZEB/miR-200 regulatory loop. This is consistent with experimental report (11). Furthermore, activation of the second switch depends on activation of the first switch. Taken together, the two-step dynamics of EMT results from sequential activation of two bistable switches, which are governed by SNAIL/miR-34 and ZEB/miR-200 double-negative feedback loops.
Manipulation of the autocrine TGF-β modifies the irreversibility of the full EMT
The results discussed above show that the autocrine expression of TGF-β is activated when the second bistable switch is turned on. To further investigate the role of autocrine expression of TGF-β on the dynamics of EMT, we perform in silico experiments of adding a constant TGF-β expression inhibitor or miR-200 expression activator. Fig. 6 A shows that the thresholds SN1∼3 barely change with the inhibitor level. On the other hand, the threshold for the deactivated of the second bistable switch (SN4) changes from negative to positive with increasing the inhibitor level. The same goes for the dependence of SN4 on miR-200 activator level (see Fig. S2), an alternative way to perturbing TGF-β expression. That is, the second bistable switch is turned to be reversible when the TGF-β inhibition or miR-200 activation is large enough. The bifurcation diagrams in Fig. 6 B and Fig. S2 B clearly show this transition from an irreversible (wild-type) to a reversible (mutant) switch.
Figure 6.

Irreversibility of full EMT is maintained by the endogenous TGF-β expression. (A) Dependence of four bifurcation points on the level of endogenous TGF-β expression inhibitor. (B) Bifurcation diagrams of N-cadherin depending on the exogenous level of TGF-β for wild-type cells (curves) and mutant cells (curves with circles) with inhibited endogenous expression of TGF-β.
Thus, the irreversibility of the second bistable switch is only relative. It can be tuned by modulating signals in addition to the exogenous TGF-β, explaining the stable yet reversible feature of EMT. Taken together, release of the inhibition of miR-200 on autocrine expression of TGF-β is responsible for the irreversibility of the full EMT induction. This is consistent with experimental results that maintenance of a stable mesenchymal phenotype requires the establishment of autocrine TGF-β signaling (11). It should be noted that the irreversibility of the full EMT is cell-type-dependent. It has been shown that the transition to mesenchymal state is stabilized after prolonged exogenous TGF-β treatment in MDCK cells after withdrawal of the TGF-β (11), but it cannot be sustained long term after TGF-β is withdrawn in epithelial NMuMG cells (35). The reason for this difference is presently not well understood and needs further study. Our results suggest one possibility is either reduced expression of autocrine TGF-β or overexpression of miR-200 in this cell line compared to others.
The requirement of the autocrine expression of TGF-β on the irreversibility of EMT indicates that the conversion from mesenchymal to epithelial (MET) needs suppression of endogenous TGF-β signaling by exogenous factors to prevent self-perpetuation of EMT. Actually, during the initiation phase of reprogramming of mouse fibroblasts, exogenous factors OSKM (Oct4, Sox2, Klf4, Myc) suppress TGF-β signaling (36), both Oct4/Sox2 and BMP can directly activate miR-200 to induce MET (37,38). These results are consistent with our finding here that it needs to turn the second bistable switch to be reversible for induction of MET by inhibiting the autocrine expression of TGF-β. Interestingly, a partial MET state exists in the transition from the M to the EMT state (see Fig. S3). Consistently, there is one experimental report on the partial MET state (39).
Influences of the intrinsic and extrinsic noise on the epithelial to mesenchymal transition
Cells face various kinds of uncertainties, such as intrinsic noises and extrinsic variations. The intrinsic noises come from low numbers of molecules per cell, such as miRNAs in our model, whereas the extrinsic noises result from parameter variations due to fluctuations of the environment including other cellular components. They generate phenotypic heterogeneity at the population level.
Fig. 7 A shows 50 typical simulated stochastic trajectories of cells at 2 units of exogenous TGF-β. The biphasic dynamics survives inclusion of noises, although the level of N-cadherin in pEMT state and M state varies from cell to cell. It is noted that the backward transition from the pEMT to the E state in Fig. 7 A is very rare. This asymmetry of forward and backward transition rates is related to hysteresis, a prominent property of a bistable system. That is, the required TGF-β concentration to induce the forward transition is higher than that to induce the backward transition. Since we choose a TGF-β concentration that favors forward transition, the backward transition rate is very low under this level of noise. Indeed, if we consider that the exogenous concentration of TGF-β fluctuates (so it can be close to SN1 or SN2 at different times), as shown in Fig. S5, one can observe more frequent forward/backward transitions between the pEMT state and the E state.
Figure 7.

Influence of the intrinsic and extrinsic noises on the epithelial to mesenchymal transition. (A) N-cadherin dynamics of 50 cells from stochastic stimulation. (B) Distribution of the time for transition to partial EMT TpEMT and that for transition to mesenchymal state TEMT. (C) The percentage of cell fates as a function of time. (D) N-cadherin distribution at different time points. The exogenous level of TGF-β treatment is 2.0.
More prominent cell-to-cell variation is the time a cell is converted to pEMT, denoted as TpEMT, and the time of transition to M state, TEMT. Both the distributions of TpEMT and TEMT, especially that of TEMT, show broad distributions either when incorporating extrinsic and intrinsic noise (Fig. 7 B) or only intrinsic noise (see Fig. S4). This is consistent with the sensitivity analysis in Fig. 4: the threshold for activation of full EMT (SN3) is more sensitive to parameter variation than the threshold for activation of pEMT (SN1).
The time evolution of each subpopulation in Fig. 7 C shows typical three-state dynamics at 2 units of TGF-β. Starting with cells in the epithelial state, the E state cell percentage drops monotonically, the pEMT fraction firstly increases then decreases, leading to an increase of M state cells. The pEMT and M state cells coexist after a long time because the TGF-β concentration is within the bistable region. We note that even at the end of the simulation, 20 days, a significant portion of cells remain in the E state, which is beyond the expectation from a simple exponential decay dynamics. The evolution over time is more clearly seen from the snapshots in Fig. 7 D. The 2000 simulated cells initially have a narrow distribution centered at low N-cadherin levels, then gradually another peak with medium N-cadherin level appears and grows to dominate over the low N-cadherin peak, followed by appearance of the third peak with high N-cadherin levels. One can experimentally test on these dynamic behaviors using flow cytometry measurements.
Discussion
The core regulatory network is designed to be robust against fluctuations and response differentially to signals with different strength and duration
Epithelial cells form the densely packed top layer of cavities, glands, and other structures throughout the body. Each individual cell adheres to its neighbors tightly and is immobile. On the other hand, mesenchymal cells are loosely connected to each other, and thus easy to move. Conversion between these two distinct phenotypes requires global change of the transcription program (3), and is expected to be tightly regulated to prevent inadvertent transitions. At certain physiological conditions, such as wound healing, however, some epithelial cells need to respond to certain stimuli, migrate to the target site, and then convert back to epithelial cells after the stimulus has been removed, e.g., after the wound healing process is finished. Therefore, the regulatory network has the combined functional requirements of being both robust against stochastic fluctuations and flexible to convert between the immobile and migratory phenotypes reversibly.
Our analyses in this work suggest that the EMT core regulatory network has evolved in several aspects to achieve the above requirements. The basic structure of the network is a cascade of two self-activation motifs. Each of the motifs serves as a bistable switch, with the end product of the first one, SNAIL1, serving as the trigger for the second switch. This allows the existence of an intermediate state, the partial EMT state, with only the first switch turned on, at intermediate stimulus strength and duration, as shown in Fig. 2 A and Fig. 3. Fig. 8 summarizes the overall picture of the whole process. Upon removal of the external stimulus, this partial EMT state switches back to the epithelial state because no mechanism exists to sustain the state. The two switches are further connected by a miR-200/TGF-β mediated positive feedback. Consequently, with sufficiently long and strong exogenous stimulus to turn on the second switch, TGF-β can be produced endogenously, allowing the switch to remain at the on-state even after removing exogenous TGF-β.
Figure 8.

Schematic depiction of the mechanism of EMT. In epithelial cells, expression of SNAIL1 and ZEB is inhibited by miR-34 and miR-200, respectively. Under treatment of exogenous TGF-β, cells first transit into a partial EMT state by the first reversible bistable switch, which is governed by the SNAIL1/miR-34 double-negative feedback loop. Then if the strength and duration of treatment are large enough, cells transit to the mesenchymal state by the second irreversible bistable switch, which is governed by ZEB/miR-200 and the autocrine expression of TGF-β. Shown for each molecular species (node): (dark-shaded box) high expression level; (light-shaded box) low expression level; whereas(solid lines) activated regulation; (dashed lines) inactivated regulation.
Each switch is composed of a double-negative feedback loop mediated with miRNAs. This network motif is known for generating delayed responses (40). The delay is further facilitated by the long time required to remove the inhibiting miRNAs, which have very long half-life and their concentrations are mainly reduced by cell-division-related dilution. The delayed responses serve as low-pass filters to prevent unregulated cell phenotypic transitions due to transient TGF-β concentration fluctuations within the in vivo microenvironment surrounding a cell.
Due to intrinsic and extrinsic noises, we predict that EMT shows stochastic transition dynamics with a broad distribution of the transition time and varying sensitivity to TGF-β. The population relaxation in Fig. 7 C is slower than an exponential decay process, which is analogous to the dynamics disorder phenomenon observed in macromolecule dynamics (41,42). This heterogeneous response within a population may have evolutionary advantage for generating an even broader response spectrum and preventing exhaustion of the whole population with a single stimulation.
Our model analyses make several experimentally testable predictions
Although seemingly simple, the regulatory network shown in Fig. 1 gives rise to complex dynamic features. Theoretical analysis as done in this work provides essential guidance for experimental studies on the structure-function relations of the network. Table 1 summarizes the published experimental reports that are qualitatively consistent with our simulation results, but more systematic quantitative measurements are necessary. Furthermore, several important new testable predictions await confirmation. Below we suggest a list of experimental studies.
Table 1.
Summary of predictions and experimental support of simulation results
| Description | Ref. |
|---|---|
| EMT is a sequential two-step program, with two distinct phases in EMT (initiation and maintenance). | (58) |
| Partial EMT retains incomplete decrease of the epithelial marker and also shows features of the mesenchymal marker. | (59) |
| Short-term TGF-β treatment causes a partial, reversible EMT (pEMT). | (11,60,61) |
| Complete EMT requires minimal strength and duration of TGF-β treatment. | (11) |
| SNAIL1 is uniquely required for the initiation of TGF-β-induced EMT, and an essential early mediator of activation of the ZEB/miR-200 pathway. | (51,58) |
| TGF-β induces EMT via upregulation of SNAIL1 at early states of the transition while subsequent expression of ZEB maintains the mesenchymal, migratory phenotype. | (51,62) |
| SNAIL1 initiates the repression of E-cadherin expression, and ZEB is required for the completed inhibition. | (17,63) |
| Two-phasic behavior is governed by a cascade process of one reversible and one irreversible bistable switch. | Prediction |
| The SNAIL1/miR-34 double-negative feedback loop is responsible for the first bistable reversible switch, and triggers the initiation of EMT. | Prediction |
| The ZEB/miR-200 double-negative feedback loop is accountable for the second bistable irreversible switch. | Prediction |
| Release of the miR-200-mediated inhibition on autocrine TGF-β makes the complete EMT irreversible. | (11) |
First, in Fig. 2 we predict that at intermediate exogenous TGF-β concentration, concentrations of the molecular species associated with the first switch, but not those of the second switch, change significantly, whereas at high exogenous TGF-β concentration, the two switches turn on in sequence. Existing studies only report the time course of E-cadherin or N-cadherin, and the data points are too sparse to unambiguously tell the predicted biphasic dynamics. Therefore, detailed quantitative time-course and steady-state measurements on multiple involved molecular species are necessary for characterizing the system dynamics and unraveling its mechanism.
Second, the bifurcation diagrams shown in Fig. 3 A and Fig. 5 A and the result in Fig. 7 can be tested using some standard procedures. Through slowly varying the exogenous TGF-β concentration as indicated in Fig. 3 A, the model predicts that the N-cadherin level (which can be measured by methods such as Western blot) shows hysteresis—that is, at a given exogenous TGF-β concentration within a bistable region, the N-cadherin level is different depending on whether the cells are originally prepared with low or high exogenous TGF-β concentrations. This procedure follows that used in the classical studies of Sha et al. (43) and Pomerening et al. (44) to confirm the bistable cell-cycle transitions in Xenopus laevis egg extracts predicted by the Tyson-Novak model (45). The hysteretic dynamics predicted in Fig. 5 A can be tested similarly. More directly, the multimodal distributions predicted in Fig. 7 can be tested with flow cytometry, which have been used in other studies demonstrating multistability of cellular systems (33). Microfluidic devices in combination with some fluorescence labeling may facilitate systematic measurements under different conditions, such as TGF-β stimulation, with different values of strength and duration, as predicted in Fig. 3 B. Further molecular interference, such as siRNA, may test how varying strengths of different interactions affects the reversibility of each switch, as predicted in Fig. 5 B and Fig. 6 B. The new experimental data can then be fed into the mathematical model for further analysis.
Third, our numerical analysis suggests possible missing regulation mechanism for miRNAs. Studies show that miRNAs are very stable and have a bare half-life of ∼120 h (46). Therefore, change of the cellular concentration of miRNAs is mainly due to cell division and growth-related dilution, which gives an effective half-life of one cell-cycle time. We use this half-life time in all the results reported in the main text. However, the MCF10A data shown in Fig. S1 reveals a much faster dynamics. We have to use a smaller half-life of miRNAs, ∼5 h, to reproduce the data. We thus suggest the dynamics of miRNAs may be regulated by additional mechanisms not reported for this system. Possible mechanisms include some post-transcriptional regulated degradation of miRNAs (47) or competitive inhibition of miRNAs (48). Alternatively, another pathway other than miRNAs may exist to regulate SNAIL1 and E-cadherin expression and responses to TGF-β. Explicit time course measurements of the miRNAs, as shown in Fig. S1, will help on clarifying this seemingly controversy.
Several directions exist on future computational/experimental studies
The regulation of EMT is controlled in several layers including the transcription, translation, post-translation, the noncoding RNA, the stability, and the subcellular localization (49). Recent evidence shows that epigenetic changes across the genome also occur during EMT (50), and prolonged treatment of TGF-β leads to DNA hypermethylation of the miR-200 promoters (11). Here, we only focus on the transcriptional, translational, and noncoding RNA layers, and leave inclusion of other layers for future studies.
In this work we only consider the core regulatory network, and other regulators in EMT are not treated here, such as Smad (21), Twist (51), and other microRNAs (5). These regulators are either the upstream of SNAIL1/ZEB or more cell-dependent than that of SNAIL1 and ZEB. Furthermore, several other signaling pathways, such as Wnt, Notch, and Ras-MAPK, can cooperate with TGF-β to induce EMT (3). It is an interesting and important question how these factors and pathways work cooperatively to regulate the dynamics of EMT.
When endogenous TGF-β molecules are induced and secreted out of cells, the extracellular TGF-β in the local cellular environment increases, inducing EMT from more cells. That is, there is some autoactivation effect among cells at the tissue level. In this work we assume that TGF-β diffusion is fast at the experimental culturing conditions, and thus the extracellular TGF-β concentration is uniform. At the tissue level where cells are densely packed in three dimensions, some TGF-β gradient may be established. It is interesting to investigate this effect and its physiological consequences by building a spatial model with cell-cell communication combined with other, related experimental studies in the future.
Reports exist that the miR-200 and miR-34 are targets of the tumor suppressor p53 (52). That is, both ZEB/miR-200 and SNAIL1/miR-34 double-negative feedback loops are regulated by p53. Thus, in addition to the conventional roles of regulating cell cycle arrest, senescence, and apoptosis, p53 has a regulating role in controlling EMT-MET plasticity. Because inappropriate occurrence of EMT leads to cancer metastasis (49,53), it is interesting to explore the role of p53 in cancer metastasis through regulating EMT. It also reported that EMT is regulated by the PI3K/PTEN/AKT pathway through Twist and Snail (54), and the PI3K/PTEN/AKT pathway also plays an important role in cell-fate decision when coupled with the p53 signaling pathway (55,56). In addition, various reports show that the ZEB family also links EMT with cell cycle control, apoptosis, and senescence (57). Thus, another important question to be answered is how cell fates are decided among EMT, apoptosis, and cell cycle arrest.
The reverse process of EMT, MET, is a key step in cell reprogramming. It has been shown that MET is the first step during the reprogramming of mouse fibroblasts into iPSCs by exogenous factors OSKM (Oct4, Sox2, Klf4, Myc), which suppress TGF-β signaling (36). It also has been shown that BMP-dependent activation of miR-200 cooperates with OSKM, which drives MET during the initiation phase of reprogramming of mouse fibroblasts (37). Recently, it is found that Oct4/Sox2 can also directly activate miR-200 (38). As the reverse process of MET, the mechanism of EMT presented here may provide clues for improving the efficiency of cell reprogramming. Furthermore, EMT is associated with stemness properties and is potentially involved in cancer stem cells, because stem cell factors, such as Sox2 and Klf4, are also candidate targets of the miR-200 family (6). Understanding the underlying mechanism will give some ideas for effective therapeutic strategy to prevent tumor metastasis.
Acknowledgments
We thank Dr John J.Tyson for helpful discussions.
This work has been supported by National Science Foundation grant Nos. DMS-0969417 and DGE-0966125 and National Institutes of Health grant No. AI099120.
Supporting Material
References
- 1.Radisky D.C. Epithelial-mesenchymal transition. J. Cell Sci. 2005;118:4325–4326. doi: 10.1242/jcs.02552. [DOI] [PubMed] [Google Scholar]
- 2.Nieto M.A. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu. Rev. Cell Dev. Biol. 2011;27:347–376. doi: 10.1146/annurev-cellbio-092910-154036. [DOI] [PubMed] [Google Scholar]
- 3.Thiery J.P., Acloque H., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871–890. doi: 10.1016/j.cell.2009.11.007. [DOI] [PubMed] [Google Scholar]
- 4.Heldin C.-H., Landström M., Moustakas A. Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 2009;21:166–176. doi: 10.1016/j.ceb.2009.01.021. [DOI] [PubMed] [Google Scholar]
- 5.Lamouille S., Subramanyam D., Derynck R. Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 2013;25:200–207. doi: 10.1016/j.ceb.2013.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wellner U., Schubert J., Brabletz T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009;11:1487–1495. doi: 10.1038/ncb1998. [DOI] [PubMed] [Google Scholar]
- 7.Bracken C.P., Gregory P.A., Goodall G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008;68:7846–7854. doi: 10.1158/0008-5472.CAN-08-1942. [DOI] [PubMed] [Google Scholar]
- 8.Burk U., Schubert J., Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582–589. doi: 10.1038/embor.2008.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Siemens H., Jackstadt R., Hermeking H. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle. 2011;10:4256–4271. doi: 10.4161/cc.10.24.18552. [DOI] [PubMed] [Google Scholar]
- 10.Kim N.H., Kim H.S., Yook J.I. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 2011;195:417–433. doi: 10.1083/jcb.201103097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gregory P.A., Bracken C.P., Goodall G.J. An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol. Biol. Cell. 2011;22:1686–1698. doi: 10.1091/mbc.E11-02-0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Leroy P., Mostov K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell. 2007;18:1943–1952. doi: 10.1091/mbc.E06-09-0823. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Revenu C., Gilmour D. EMT 2.0: shaping epithelia through collective migration. Curr. Opin. Genet. Dev. 2009;19:338–342. doi: 10.1016/j.gde.2009.04.007. [DOI] [PubMed] [Google Scholar]
- 14.Klymkowsky M.W., Savagner P. Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am. J. Pathol. 2009;174:1588–1593. doi: 10.2353/ajpath.2009.080545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thomson S., Petti F., Haley J.D. A systems view of epithelial-mesenchymal transition signaling states. Clin. Exp. Metastasis. 2011;28:137–155. doi: 10.1007/s10585-010-9367-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Futterman M.A., García A.J., Zamir E.A. Evidence for partial epithelial-to-mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev. Dyn. 2011;240:1502–1511. doi: 10.1002/dvdy.22607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.de Herreros A.G., Peiró S., Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J. Mammary Gland Biol. Neoplasia. 2010;15:135–147. doi: 10.1007/s10911-010-9179-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Lee J.M., Dedhar S., Thompson E.W. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol. 2006;172:973–981. doi: 10.1083/jcb.200601018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Vilar J.M.G., Jansen R., Sander C. Signal processing in the TGF-β superfamily ligand-receptor network. PLOS Comput. Biol. 2006;2:e3. doi: 10.1371/journal.pcbi.0020003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Zi Z., Klipp E. Constraint-based modeling and kinetic analysis of the Smad dependent TGF-β signaling pathway. PLoS ONE. 2007;2:e936. doi: 10.1371/journal.pone.0000936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Schmierer B., Tournier A.L., Hill C.S. Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc. Natl. Acad. Sci. USA. 2008;105:6608–6613. doi: 10.1073/pnas.0710134105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Turner C., Kohandel M. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: a mathematical approach. J. Theor. Biol. 2010;265:329–335. doi: 10.1016/j.jtbi.2010.05.024. [DOI] [PubMed] [Google Scholar]
- 23.Vilar J.M., Saiz L. Trafficking coordinate description of intracellular transport control of signaling networks. Biophys. J. 2011;101:2315–2323. doi: 10.1016/j.bpj.2011.09.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Peinado H., Quintanilla M., Cano A. Transforming growth factor β-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 2003;278:21113–21123. doi: 10.1074/jbc.M211304200. [DOI] [PubMed] [Google Scholar]
- 25.Rosenfeld N., Young J.W., Elowitz M.B. Gene regulation at the single-cell level. Science. 2005;307:1962–1965. doi: 10.1126/science.1106914. [DOI] [PubMed] [Google Scholar]
- 26.Alon U. Chapman & Hall/CRC; London: 2007. An Introduction to Systems Biology: Design Principles of Biological Circuits, Vol. 10. [Google Scholar]
- 27.Paulsson J. Summing up the noise in gene networks. Nature. 2004;427:415–418. doi: 10.1038/nature02257. [DOI] [PubMed] [Google Scholar]
- 28.Vilar J.M.G., Kueh H.Y., Leibler S. Mechanisms of noise-resistance in genetic oscillators. Proc. Natl. Acad. Sci. USA. 2002;99:5988–5992. doi: 10.1073/pnas.092133899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Marquez-Lago T.T., Burrage K. Binomial τ-leap spatial stochastic simulation algorithm for applications in chemical kinetics. J. Chem. Phys. 2007;127:104101. doi: 10.1063/1.2771548. [DOI] [PubMed] [Google Scholar]
- 30.Cao Y., Gillespie D.T., Petzold L.R. Adaptive explicit-implicit tau-leaping method with automatic τ-selection. J. Chem. Phys. 2007;126:224101. doi: 10.1063/1.2745299. [DOI] [PubMed] [Google Scholar]
- 31.Tyson J.J., Chen K.C., Novak B. Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr. Opin. Cell Biol. 2003;15:221–231. doi: 10.1016/s0955-0674(03)00017-6. [DOI] [PubMed] [Google Scholar]
- 32.Ferrell J.E., Jr. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr. Opin. Cell Biol. 2002;14:140–148. doi: 10.1016/s0955-0674(02)00314-9. [DOI] [PubMed] [Google Scholar]
- 33.Yao G., Lee T.J., You L. A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 2008;10:476–482. doi: 10.1038/ncb1711. [DOI] [PubMed] [Google Scholar]
- 34.Tian X.J., Zhang X.P., Wang W. Interlinking positive and negative feedback loops creates a tunable motif in gene regulatory networks. Phys. Rev. E. 2009;80:011926. doi: 10.1103/PhysRevE.80.011926. [DOI] [PubMed] [Google Scholar]
- 35.Gal A., Sjöblom T., Moustakas A. Sustained TGF β-exposure suppresses Smad and non-Smad signaling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene. 2008;27:1218–1230. doi: 10.1038/sj.onc.1210741. [DOI] [PubMed] [Google Scholar]
- 36.Li R., Liang J., Pei D. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell. 2010;7:51–63. doi: 10.1016/j.stem.2010.04.014. [DOI] [PubMed] [Google Scholar]
- 37.Samavarchi-Tehrani P., Golipour A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell. 2010;7:64–77. doi: 10.1016/j.stem.2010.04.015. [DOI] [PubMed] [Google Scholar]
- 38.Wang G., Guo X., Kang J. Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc. Natl. Acad. Sci. USA. 2013;110:2858–2863. doi: 10.1073/pnas.1212769110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Chao Y., Wu Q., Wells A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron. 2012;5:19–28. doi: 10.1007/s12307-011-0085-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Alon U. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 2007;8:450–461. doi: 10.1038/nrg2102. [DOI] [PubMed] [Google Scholar]
- 41.Zwanzig R. Rate processes with dynamical disorder. Acc. Chem. Res. 1990;23:148–152. [Google Scholar]
- 42.English B.P., Min W., Xie X.S. Ever-fluctuating single enzyme molecules: Michaelis-Menten equation revisited. Nat. Chem. Biol. 2006;2:87–94. doi: 10.1038/nchembio759. [DOI] [PubMed] [Google Scholar]
- 43.Sha W., Moore J., Sible J.C. Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts. Proc. Natl. Acad. Sci. USA. 2003;100:975–980. doi: 10.1073/pnas.0235349100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Pomerening J.R., Sontag E.D., Ferrell J.E., Jr. Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2. Nat. Cell Biol. 2003;5:346–351. doi: 10.1038/ncb954. [DOI] [PubMed] [Google Scholar]
- 45.Novak B., Tyson J.J. Numerical analysis of a comprehensive model of M-phase control in Xenopus oocyte extracts and intact embryos. J. Cell Sci. 1993;106:1153–1168. doi: 10.1242/jcs.106.4.1153. [DOI] [PubMed] [Google Scholar]
- 46.Gantier M.P., McCoy C.E., Williams B.R.G. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39:5692–5703. doi: 10.1093/nar/gkr148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell. 2010;38:323–332. doi: 10.1016/j.molcel.2010.03.013. [DOI] [PubMed] [Google Scholar]
- 48.Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods. 2007;4:721–726. doi: 10.1038/nmeth1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.De Craene B., Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer. 2013;13:97–110. doi: 10.1038/nrc3447. [DOI] [PubMed] [Google Scholar]
- 50.McDonald O.G., Wu H., Feinberg A.P. Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat. Struct. Mol. Biol. 2011;18:867–874. doi: 10.1038/nsmb.2084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Dave N., Guaita-Esteruelas S., de Herreros A.G. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 2011;286:12024–12032. doi: 10.1074/jbc.M110.168625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hermeking H. MicroRNAs in the p53 network: micromanagement of tumor suppression. Nat. Rev. Cancer. 2012;12:613–626. doi: 10.1038/nrc3318. [DOI] [PubMed] [Google Scholar]
- 53.Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science. 2011;331:1559–1564. doi: 10.1126/science.1203543. [DOI] [PubMed] [Google Scholar]
- 54.Hao L., Ha J.R., Persad S. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail. Br. J. Dermatol. 2012;166:1184–1197. doi: 10.1111/j.1365-2133.2012.10824.x. [DOI] [PubMed] [Google Scholar]
- 55.Zhang X.P., Liu F., Wang W. Two-phase dynamics of p53 in the DNA damage response. Proc. Natl. Acad. Sci. USA. 2011;108:8990–8995. doi: 10.1073/pnas.1100600108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Tian X.-J., Liu F., Wang W. A two-step mechanism for cell fate decision by coordination of nuclear and mitochondrial p53 activities. PLoS ONE. 2012;7:e38164. doi: 10.1371/journal.pone.0038164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Browne G., Sayan A.E., Tulchinsky E. ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle. 2010;9:886–891. doi: 10.4161/cc.9.5.10839. [DOI] [PubMed] [Google Scholar]
- 58.Ansieau S., Bastid J., Puisieux A. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell. 2008;14:79–89. doi: 10.1016/j.ccr.2008.06.005. [DOI] [PubMed] [Google Scholar]
- 59.Jechlinger M., Sommer A., Grünert S. Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 2006;116:1561–1570. doi: 10.1172/JCI24652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Waerner T., Alacakaptan M., Beug H. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell. 2006;10:227–239. doi: 10.1016/j.ccr.2006.07.020. [DOI] [PubMed] [Google Scholar]
- 61.Thuault S., Tan E.-J., Moustakas A. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J. Biol. Chem. 2008;283:33437–33446. doi: 10.1074/jbc.M802016200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumor progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer. 2007;7:415–428. doi: 10.1038/nrc2131. [DOI] [PubMed] [Google Scholar]
- 63.Brabletz S., Brabletz T. The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11:670–677. doi: 10.1038/embor.2010.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Brabletz T. MiR-34 and SNAIL: another double-negative feedback loop controlling cellular plasticity/EMT governed by p53. Cell Cycle. 2012;11:215–216. doi: 10.4161/cc.11.2.18900. [DOI] [PubMed] [Google Scholar]
- 65.Braun J., Hoang-Vu C., Hüttelmaier S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene. 2010;29:4237–4244. doi: 10.1038/onc.2010.169. [DOI] [PubMed] [Google Scholar]
- 66.Wang B., Koh P., Kantharidis P. miR-200a prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes. 2011;60:280–287. doi: 10.2337/db10-0892. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Cano A., Pérez-Moreno M.A., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000;2:76–83. doi: 10.1038/35000025. [DOI] [PubMed] [Google Scholar]
- 68.Batlle E., Sancho E., García De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat. Cell Biol. 2000;2:84–89. doi: 10.1038/35000034. [DOI] [PubMed] [Google Scholar]
- 69.Shirakihara T., Saitoh M., Miyazono K. Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mesenchymal transition induced by TGF-β. Mol. Biol. Cell. 2007;18:3533–3544. doi: 10.1091/mbc.E07-03-0249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Moreno-Bueno G., Cubillo E., Cano A. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66:9543–9556. doi: 10.1158/0008-5472.CAN-06-0479. [DOI] [PubMed] [Google Scholar]
- 71.Zhou B.P., Deng J., Hung M.-C. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 2004;6:931–940. doi: 10.1038/ncb1173. [DOI] [PubMed] [Google Scholar]
- 72.Vandewalle C., Comijn J., Berx G. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005;33:6566–6578. doi: 10.1093/nar/gki965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Sharova L.V., Sharov A.A., Ko M.S. Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res. 2009;16:45–58. doi: 10.1093/dnares/dsn030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Schwanhäusser B., Busse D., Selbach M. Global quantification of mammalian gene expression control. Nature. 2011;473:337–342. doi: 10.1038/nature10098. [DOI] [PubMed] [Google Scholar]
- 75.Tran D.D., Corsa C.A.S., Longmore G.D. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol. Cancer Res. 2011;9:1644–1657. doi: 10.1158/1541-7786.MCR-11-0371. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
